EP2480085
Combination comprising the MEK inhibitor N-{3-[3-cyclopropyl-5-(2-fluoro-4-iodo- phenylamino)-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydro-2H-pyrido[4,3-d]pyrimidin-1-yl]phenyl}acetamide and the Akt inhibitor N-{(1S)-2-amino-1-[(3-fluorophenyl)methyl]ethyl}-5-chloro-4-(4-chloro-1- methyl-1H-pyrazol-5-yl)-2-thiophenecarboxamide
:
EP einkaleyfi: Þýðing ekki lögð inn:
23.9.2010:
12.11.2014:
10819438.2
:
22.9.2030
:
Combination comprising the MEK inhibitor N-{3-[3-cyclopropyl-5-(2-fluoro-4-iodo- phenylamino)-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydro-2H-pyrido[4,3-d]pyrimidin-1-yl]phenyl}acetamide and the Akt inhibitor N-{(1S)-2-amino-1-[(3-fluorophenyl)methyl]ethyl}-5-chloro-4-(4-chloro-1- methyl-1H-pyrazol-5-yl)-2-thiophenecarboxamide
23.9.2010
12.11.2014
:
Novartis AG:
Lichtstrasse 35, 4056, Basel, CH
:
DUMBLE, Melissa:
PiscatawayNJ, US
:
GILMER, Tona:
Research Triangle ParkNC, US
:
KUMAR, Rakesh:
CollegevillePA, US
:
LEBOWITZ, Peter, F.:
CollegevillePA, US
:
MORRIS, Shannon, Renae:
Research Triangle ParkNC, US
:
LAQUERRE, Sylvie:
King Of PrussiaPA, US
:
245027 P:
23.9.2009:
US
:
WO2011038085:
23.9.2010
:
A01N 43/54, A61K 31/415, A61K 31/505